A citation-based method for searching scientific literature

Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, Johan M Kros, Mathilde C M Kouwenhoven, Jean-Yves Delattre, Hans J J A Bernsen, Marc Frenay, Cees C Tijssen, Wolfgang Grisold, László Sipos, Roelien H Enting, Pim J French, Winand N M Dinjens, Charles J Vecht, Anouk Allgeier, Denis Lacombe, Thierry Gorlia, Khê Hoang-Xuan. J Clin Oncol 2013
Times Cited: 722



Gregory Cairncross, Brian Berkey, Edward Shaw, Robert Jenkins, Bernd Scheithauer, David Brachman, Jan Buckner, Karen Fink, Luis Souhami, Normand Laperierre, Minesh Mehta, Walter Curran. J Clin Oncol 2006
Times Cited: 524




List of shared articles



Times cited

Molecular, Histological, and Clinical Characteristics of Oligodendrogliomas: A Multi-Institutional Retrospective Study.
Antonio Dono, Kristin Alfaro-Munoz, Yuanqing Yan, Carlos A Lopez-Garcia, Zaid Soomro, Garret Williford, Takeshi Takayasu, Lindsay Robell, Nazanin K Majd, John de Groot,[...]. Neurosurgery 2022
0

Executive summary of American Radium Society's appropriate use criteria for the postoperative management of lower grade gliomas.
Martin C Tom, Michael T Milano, Samuel T Chao, Scott G Soltys, Jonathan P S Knisely, Arjun Sahgal, Seema Nagpal, Simon S Lo, Siavash Jabbari, Tony J C Wang,[...]. Radiother Oncol 2022
0

Lung toxicity of lomustine in the treatment of progressive gliomas.
Corinna Seliger, Christina Nürnberg, Wolfgang Wick, Antje Wick. Neurooncol Adv 2022
0

A Population-Based Study of Treatment and Survival in Older Glioma Patients.
Anne S Reiner, Stephanie M Lobaugh, Selin Gonen, Eli L Diamond, Katherine S Panageas. JNCI Cancer Spectr 2022
1

Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors.
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, Alba A Brandes, J Gregory Cairncross, Johan M Kros, Lynn S Ashby, Martin J B Taphoorn, Luis Souhami, Winand N M Dinjens,[...]. J Clin Oncol 2022
0

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline.
Nimish A Mohile, Hans Messersmith, Na Tosha Gatson, Andreas F Hottinger, Andrew Lassman, Jordan Morton, Douglas Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffery Olson,[...]. J Clin Oncol 2022
9

Radiation guidelines for gliomas.
D Antoni, L Feuvret, J Biau, C Robert, J-J Mazeron, G Noël. Cancer Radiother 2022
0

Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Lia M Halasz, Albert Attia, Lisa Bradfield, Daniel J Brat, John P Kirkpatrick, Nadia N Laack, Nafisha Lalani, Emily S Lebow, Arthur K Liu, Heather M Niemeier,[...]. Pract Radiat Oncol 2022
0

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design.
Kurt A Jaeckle, Karla V Ballman, Martin van den Bent, Caterina Giannini, Evanthia Galanis, Paul D Brown, Robert B Jenkins, J Gregory Cairncross, Wolfgang Wick, Michael Weller,[...]. Neuro Oncol 2021
25

A basic review on systemic treatment options in WHO grade II-III gliomas.
Maximilian J Mair, Marjolein Geurts, Martin J van den Bent, Anna S Berghoff. Cancer Treat Rev 2021
20

One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.
Rachel J Keogh, Razia Aslam, Maeve A Hennessy, Zac Coyne, Bryan T Hennessy, Oscar S Breathnach, Liam Grogan, Patrick G Morris. BMC Cancer 2021
3

Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Martin J van den Bent, C Mircea S Tesileanu, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Paul M Clement, Sarah Erridge, Michael A Vogelbaum, Anna K Nowak, Jean Français Baurain,[...]. Lancet Oncol 2021
35

Oligodendroglioma: A Review of Management and Pathways.
Maroun Bou Zerdan, Hazem I Assi. Front Mol Neurosci 2021
2